Intravenous nicardipine dosing for blood pressure lowering in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study
- PMID: 25314943
- DOI: 10.1016/j.jstrokecerebrovasdis.2014.06.029
Intravenous nicardipine dosing for blood pressure lowering in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study
Abstract
Background: Intravenous nicardipine is commonly used to reduce elevated blood pressure in acute intracerebral hemorrhage (ICH). We determined factors associated with nicardipine dosing and the association of dose with clinical outcomes in hyperacute ICH.
Methods: Hyperacute (<3 hours from onset) ICH patients with initial systolic blood pressure (SBP) greater than 180 mm Hg were included. All patients initially received 5 mg/hour of intravenous nicardipine. The dose was adjusted to maintain SBP between 120 and 160 mm Hg. Associations of maximum hourly and total doses with early neurologic deterioration (END), hematoma expansion (>33%), and modified Rankin Scale score 4-6 at 3 months were assessed.
Results: Two hundred six patients (81 women, 65.8 ± 11.8 years) were studied. Initial SBP was 201.9 ± 15.9 mm Hg. Maximum and total nicardipine doses were 9.1 ± 4.2 mg/hour and 123.7 ± 100.2 mg/day, respectively. Multivariate analyses revealed that men (standardized regression coefficient [β] = .20, P = .0030 for maximum dose; β = .25, P = .0002 for total dose), age (β = -.28, P = .0002; β = -.25, P = .0005), and initial SBP (β = .19, P = .0018; β = .18, P = .0021) were independently associated with both maximum and total doses. Body weight (β = .20, P = .0084) was independently associated with total dose. After multivariate adjustment, maximum dose (per 1 mg/hour; odds ratio [OR], 1.25; 95% confidence interval [CI], 1.09-1.45) was independently, and total dose (per 10 mg/day; OR, 1.06; 95% CI, .998-1.132) tended to be independently, associated with END. Nicardipine dose was not associated with hematoma expansion or 3-month outcome.
Conclusions: Nicardipine dose is roughly predictable with sex, age, body weight, and initial SBP in acute ICH. The maximum dose was associated with neurologic deterioration.
Keywords: Acute stroke; blood pressure; calcium-channel blocker; intracerebral hemorrhage; nicardipine.
Copyright © 2014 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Early Achievement of Blood Pressure Lowering and Hematoma Growth in Acute Intracerebral Hemorrhage: Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement-Intracerebral Hemorrhage Study.Cerebrovasc Dis. 2018;46(3-4):118-124. doi: 10.1159/000492728. Epub 2018 Sep 10. Cerebrovasc Dis. 2018. PMID: 30199854
-
Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study.Arch Neurol. 2010 May;67(5):570-6. doi: 10.1001/archneurol.2010.61. Arch Neurol. 2010. PMID: 20457956 Free PMC article. Clinical Trial.
-
Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage: a prospective, multicenter, observational study (the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study).J Hypertens. 2012 Dec;30(12):2357-64. doi: 10.1097/HJH.0b013e328359311b. J Hypertens. 2012. PMID: 22990355 Clinical Trial.
-
Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review.Int J Stroke. 2022 Jun;17(5):494-505. doi: 10.1177/17474930211044635. Epub 2021 Sep 20. Int J Stroke. 2022. PMID: 34542358
-
Intravenous nicardipine for Japanese patients with acute intracerebral hemorrhage: an individual participant data analysis.Hypertens Res. 2023 Jan;46(1):75-83. doi: 10.1038/s41440-022-01046-4. Epub 2022 Oct 13. Hypertens Res. 2023. PMID: 36224285 Free PMC article.
Cited by
-
The L-shaped correlation between systolic blood pressure and short-term and long-term mortality in patients with cerebral hemorrhage.BMC Neurol. 2023 Jun 14;23(1):230. doi: 10.1186/s12883-023-03271-x. BMC Neurol. 2023. PMID: 37316781 Free PMC article.
-
Modulating the Immune Response Towards a Neuroregenerative Peri-injury Milieu After Cerebral Hemorrhage.J Neuroimmune Pharmacol. 2015 Dec;10(4):576-86. doi: 10.1007/s11481-015-9613-1. Epub 2015 May 7. J Neuroimmune Pharmacol. 2015. PMID: 25946986 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical